Retinoids in nephrology: Promises and pitfalls

Kidney International

Volumn 66, Issue 6, 2004, Pages 2119-2131

  Xu, Qihe ^a   Lucio Cazana, Javier ^b   Kitamura, Masanori ^b   Ruan, Xiongzhong ^b   Fine, Leon G ^b   Norman, Jill T ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

Fibrosis; Inflammation; Kidney diseases; Retinoids; Side effects

Indexed keywords

CELL NUCLEUS RECEPTOR; PUROMYCIN AMINONUCLEOSIDE; RETINOID; STEROID; VITAMIN RECEPTOR;

ACUTE GRAFT REJECTION; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; CELL PROTECTION; CELL TYPE; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFECT; FIBROBLAST; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; IMMUNOMODULATION; INFLAMMATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY CELL; KIDNEY DISEASE; KIDNEY TUBULE CELL; LIPID STORAGE; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE; MACROPHAGE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; MUTATION; NEPHROLOGY; NEPHROSIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; RETINOL DEFICIENCY; REVIEW; SIDE EFFECT; SMOOTH MUSCLE FIBER; TERATOGENICITY; ANIMAL; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HUMANS; KIDNEY; KIDNEY DISEASES; NEPHROLOGY; RETINOIDS;

EID: 21644480926     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.66002.x     Document Type: Article

References (100)

1. WAGNER J, DECHOW C, MORATH C, et al: Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol 11:1479-1487, 2000
2. LEHRKE I, SCHAIER M, SCHADE K, et al: Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. Am J Physiol Renal Physiol 282:F741-F751, 2002
3. SCHAIER M, LEHRKE I, SCHADE K, et al: Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int 60:2222-2234, 2001
4. SCHAIER M, LIEBLER S, SCHADE K, et al: Retinoic acid α and retinoid x receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med 82:116-125, 2004
5. MORENO-MANZANO V, MAMPASO F, SEPULVEDA-MUNOZ JC, et al: Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Br J Pharmacol 139:823-831, 2003
6. SUZUKI A, ITO T, IMAI E, et al: Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. J Am Soc Nephrol 14:981-991, 2003
7. KINOSHITA K, YOO BS, NOZAKI Y, et al: Retinoic acid reduces autoimmune renal injury and increases survival in NZBAV F(1) mice. J Immunol 170:5793-5798, 2003
8. KISS E, ADAMS J, GRONE HJ, et al: Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. Transplantation 76:480-489, 2003
9. MORENO-MANZANO V, RODRIGUEZ-PUYOL M, ARRIBAS-GOMEZ I, et al: Prevention by tretinoin (all-trans-retinoic acid) of age-related renal changes. Int J Vitam Nutr Res 67:427-431, 1997
10. MANZANO VM, PUYOL MR, PUYOL DR, LUCIO-CAZANA J: Tretinoin prevents age-related renal changes and stimulates antioxidant defenses in cultured renal mesangial cells. J Pharmacol Exp Ther 289:123-132, 1999
11. SCHAIER M, JOCKS T, GRONE HJ, et al: Retinoid agonist isotretinoin ameliorates obstruction renal injury. J Urol 170:1398-1402, 2003
12. KAVUKCU S, SOYLU A, TURKMEN M, et al: The role of vitamin A in preventing renal scarring secondary to pyelonephritis. BJU Int 83:1055-1059, 1999
13. BENNETT RT, MAZZACCARO RJ, CHOPRA N, et al: Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats. J Urol 161:1681-1684, 1999
14. OSETO S, MORIYAMA T, KAWADA N, et al: Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 64:1241-1252, 2003
15. DATTA PK, REDDY RS, LIANOS EA: Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor β-1 production in experimental anti-GBM antibody-mediated glomerulonephritis. Inflammation 25:351-359, 2001
16. TOMITA N, KANAMORI H, FUJITA H, et al: Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid. Anticancer Drugs 12:677-680, 2001
17. MOULDER JE, FISH BL, REGNER KR, et al: Retinoic acid exacerbates experimental radiation nephropathy. Radiat Res 157:199-203, 2002
18. TURMAN MA, HAMMOND S, GROVAS A, RAUCK AM: Possible association of retinoic acid with bone marrow transplant nephropathy. Pediatr Nephrol 13:755-158, 1999
19. MANZANO VM, MUNOZ JC, JIMENEZ JR, et al: Human renal mesangial cells are a target for the anti-inflammatory action of 9-cis retinoic acid. Br J Pharmacol 131:1673-1683, 2000
20. XU Q, KONTA T, FURUSU A, et al: Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptolic effect. J Biol Chem 277:41693-41700, 2002
21. ROSS SA, MCCAFFERY PJ, DRAGER UC, DE LUCA LM: Retinoids in embryonal development. Physiol Rev 80:1021-1054, 2000
22. MARILL J, IDRES N, CAPRON CC, et al: Retinoic acid metabolism and mechanism of action: A review. Curr Drug Metab 4:1-10, 2003
23. NIEDERREITHER K, ABU-ABED S, SCHUHBAUR B, et al: Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat Genet 31:84-88, 2002
24. GRONEMEYER H, MITURSKI R: Molecular mechanisms of retinoid action. Cell Mol Biol Lett 6:3-52, 2001
25. BALMER JE, BLOMHOFF R: Gene expression regulation by retinoic acid. J Lipid Res 43:1773-1808, 2002
26. GERMAIN P, IYER J, ZECHEL C, GRONEMEYER H: Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415:187-192, 2002
27. SIMONSON MS: Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells. Am J Physiol 267:F805-F815, 1994
28. MORENO-MANZANO V, ISHIKAWA Y, LUCIO-CAZANA J, KITAMURA M: Suppression of apoptosis by all-trans-retinoic acid. Dual intervention in the c-Jun N-terminal kinase-AP-1 pathway. J Biol Chem 274:20251-20258, 1999
29. KONTA T, XU Q, FURUSU A, et al: Selective roles of retinoic acid receptor and retinoid x receptor in the suppression of apoptosis by all-trans-retinoic acid. J Biol Chem 276:12697-12701, 2001
30. SUZUKAWA K, COLBURN NH: AP-1 trans-repressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Oncogene 21:2181-2190, 2002
31. BENKOUSSA M, BRAND C, DELMOTTE MH, et al: Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol 22:4522-1534, 2002
32. LIN F, XIAO D, KOLLURI SK, ZHANG X: Unique anti-activator protein-1 activity of retinoic acid receptor β. Cancer Res 60:3271-3280, 2000
33. XU Q, KONTA T, KITAMURA M: Retinoic acid regulation of mesangial cell apoptosis. Exp Nephrol 10:171-175, 2002
34. LUCIO-CAZANA J, NAKAYAMA K, XU Q, et al: Suppression of constitutive but not IL-1β-inducible expression of monocyte chemoattractant protein-1 in mesangial cells by retinoic acids: Intervention in the activator protein-1 pathway. J Am Soc Nephrol 12:688-694, 2001
35. NA SY, KANG BY, CHUNG SW, et al: Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid x receptor and NFkappaB. J Biol Chem 274:7674-7680, 1999
36. NA SY, KIM HJ, LEE SK, et al: IkappaBβ interacts with the retinoid x receptor and inhibits retinoid-dependent transactivation in lipopolysaccharide-treated cells. J Biol Chem 273:3212-3215, 1998
37. CHADWICK CC, SHAW LJ, WINNEKER RC: TNF-α and 9-cis-retinoic acid synergistically induce ICAM-1 expression: Evidence for interaction of retinoid receptors with NF-kappa B. Exp Cell Res 239:423-429, 1998
38. DATTA PK, LIANOS EA: Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. Kidney Int 56:486-493, 1999
39. KASTNER P, MARK M, CHAMBON P, et al: Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life? Cell 83:859-869, 1995
40. KANG JX, BELL J, BEARD RL, CHANDRARATNA RA: Mannose 6-phosphate/insulin- like growth factor II receptor mediates the growth-inhibitory effect of retinoids. Cell Growth Differ 10:591-600, 1999
41. SHAW N, ELHOLM M, NOY N: Retinoic acid is a high affinity selective ligand for PPARβ/δ. J Biol Chem 278:41589-41592, 2003
42. STEHLIN-GAON C, WILLMANN D, ZEYER D, et al: All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ. Nat Struct Biol 10:820-825, 2003
43. BAYON Y, ORTIZ MA, LOPEZ-HERNANDEZ FJ, et al: Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. Mol Cell Biol 23:1061-1074, 2003
44. RADOMINSKA-PANDYA A, CHEN G, CZERNIK PJ, et al: Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). Implications for PKC signaling and cancer therapy. J Biol Chem 275:22324-22330, 2000
45. CHO Y, KLEIN MG, TALMAGE DA: Distinct functions of protein kinase Cα and protein kinase Cβ during retinoic acid-induced differentiation of F9 cells. Cell Growth Differ 9:147-154, 1998
46. IMAM A, HOYOS B, SWENSON C, et al: Retinoids as ligands and coactivators of protein kinase Ca. FASEB J 15:28-30, 2001
47. WANG H, IKEDA S, KANNO S, et al: Activation of c-Jun amino-terminal kinase is required for retinoic acid-induced neural differentiation of P19 embryonal carcinoma cells. FEBS Lett 503:91-96, 2001
48. KAMBHAMPATI S, LI Y, VERMA A, et al: Activation of protein kinase C-δ (PKC-δ) by all-trans-retinoic acid. J Biol Chem 278:32544-32551, 2003
49. HONG HY, VARVAYANIS S, YEN A: Retinoic acid causes MEK-dependent RAF phosphorylation through RARa plus RXR activation in HL-60 cells. Differentiation 68:55-66, 2001
50. ALSAYED Y, UDDIN S, MAHMUD N, et al: Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 276:4012-4019, 2001
51. BASTIEN J, ROCHETTE-EGLY C: Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328:1-16, 2004
52. LELIEVRE-PEGORIER M, VILAR J, FERRIER ML, et al: Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int 54:1455-1462, 1998
53. BATOURINA E, CHOI C, PARAGAS N, et al: Distal ureter morphogenesis depends on epithelial cell remodeling mediated by vitamin A and Ret. Nat Genet 32:109-115, 2002
54. BATOURINA E, GIM S, BELLO N, et al: Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nat Genet 27:74-78, 2001
55. BURROW CR: Retinoids and renal development. Exp Nephrol 8:219-225, 2000
56. MATSUBARA S, TAKE M, PEDRAZA C, MURAMATSU T: Mapping and characterization of a retinoic acid-responsive enhancer of midkine, a novel heparin-binding growth/differentiation factor with neurotrophic activity. J Biochem (Tokyo) 115:1088-1096, 1994
57. VILAR J, LALOU C, DUONG VH, et al: Midkine is involved in kidney development and in its regulation by retinoids. J Am Soc Nephrol 13:668-676, 2002
58. NAKAMURA E, KADOMATSU K, YUASA S, et al: Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. Genes Cells 3:811-822, 1998
59. MORITZ KM, DODIC M, WINTOUR EM: Kidney development and the fetal programming of adult disease. Bioessays 25:212-220, 2003
60. KAVUKCU S, TURKMEN MA, SOYLU A: Could the effective mechanisms of retinoids on nephrogenesis be also operative on the amelioration of injury in acquired renal lesions? Pediatr. Nephrol 16:689-690, 2001
61. MENE P, POLCI R, FESTUCCIA F: Mechanisms of repair after kidney injury. J Nephrol 16:186-195, 2003
62. DRAPER JS, PIGOTT C, THOMSON JA, ANDREWS PW: Surface antigens of human embryonic stem cells: Changes upon differentiation in culture. J Anat 200:249-258, 2002
63. SUZUKI A, IWATANI H, ITO T, et al: Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells. Kidney Int 65:15-24, 2004
64. KAKELA A, KAKELA R, HYVARINEN H: Importance of the kidneys in metabolism of vitamins A1 and A2 and their fatty acyl esters in mink feeding on fish-based diets and exposed to Aroclor 1242. Toxicol Appl Pharmacol 187:118-127, 2003
65. MORATH C, DECHOW C, LEHRKE I, et al: Effects of retinoids on the TGF-β system and extracellular matrix in experimental glomerulonephritis. J Am Soc Nephrol 12:2300-2309, 2001
66. DECHOW C, MORATH C, PETERS J, et al: Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis. Am J Physiol Renal Physiol 281:F909-F919, 2001
67. TAKEDA K, ICHIKI T, FUNAKOSHI Y, et al: Downregulation of angiotensin II type 1 receptor by all-trans retinoic acid in vascular smooth muscle cells. Hypertension 35:297-302, 2000
68. HAXSEN V, ADAM-STITAH S, RITZ E, WAGNER J: Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells. Circ Res 88:637-644, 2001
69. TAKAHASHI S, NOSE M, SASAKI J, et al: IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 147:515-519, 1991
70. CANTORNA MT, NASHOLD FE, HAYES CE: In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 152:1515-1522, 1994
71. CANTORNA MT, NASHOLD FE, CHUN TY, HAYES CE: Vitamin A down-regulation of IFN-γ synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J Immunol 156:2674-2679, 1996
72. STEPHENSEN CB: Vitamin A, infection, and immune function. Annu Rev Nutr 21:167-192, 2001
73. GERGELY P, CSAKY L, GONZALEZ-CABELLO P: Immunological effects of retinoids. Tokai J Exp Clin Med 15:235-239, 1990
74. MCKERROW KJ, MACKIE RM, LESKO MJ, PEARSON C: The effect of oral retinoid therapy on the normal human immune system. Br J Dermatol 119:313-320, 1988
75. SZONDY Z, REICHERT U, FESUS L: Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors. Cell Death Differ 5:4-10, 1998
76. ERTESVAG A, ENGEDAL N, NADERI S, BLOMHOFF HK: Retinoic acid stimulates the cell cycle machinery in normal T cells: Involvement of retinoic acid receptor-mediated IL-2 secretion. J Immunol 169:5555-5563, 2002
77. OROSZ CG, ZINN NE, BISHOP DK, et al: Analysis of retinoid-mediated immunosuppression in vivo. Effects of Ro23-6457 on cellular alloimmune responses. Immunopharmacology 22:49-58, 1991
78. DANIELPOUR D, KIM KY, WINOKUR TS, SPORN MB: Differential regulation of the expression of transforming growth factor-βs 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J Cell Physiol 148:235-244, 1991
79. ARGILES A, KRAFT NE, HUTCHINSON P, et al: Retinoic acid affects the cell cycle and increases total protein content in epithelial cells. Kidney Int 36:954-959, 1998
80. ANDERSON RJ, RAY CJ, HATTLER BG: Retinoic acid regulation of renal tubular epithelial and vascular smooth muscle cell function. J Am Soc Nephrol 9:773-781, 1998
81. SHINDO T, MANABE I, FUKUSHIMA Y, et al: Kruppel-like zinc-finger transcription factor is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 8:856-863, 2002
82. LU L, YAO T, ZHU YZ, et al: Chronic all-trans retinoic acid treatment prevents medial thickening of intramyocardial- and intrarenal arteries in spontanously hypertensive rats. Am J Physiol Heart Circ Physiol 285:H1370-H1377, 2003
83. HORIE S, ISHII H, MATSUMOTO F, et al: Acceleration of thrombomodulin gene transcription by retinoic acid: Retinoic acid receptors and Sp1 regulate the promoter activity through interactions with two different sequences in the 5′-flanking region of human gene. J Biol Chem 276:2440-2450, 2001
84. SHIMADA J, SUZUKI Y, KIM SJ, et al: Transactivation via RAR/RXR-Sp1 interaction: Characterization of binding between Sp1 and GC box motif. Mol Endocrinol 15:1677-1692, 2001
85. AOSHIMA K, ASAKURA H, YAMAZAKI M, et al: Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model. Semin Thromb Hemost 24:227-231, 1998
86. STANDEVEN AM, TENG M, CHANDRARATNA RA: Lack of involvement of retinoic acid receptor α in retinoid-induced skin irritation in hairless mice. Toxicol Lett 92:231-240, 1997
87. CHEN S, OSTROWSKI J, WHITING G, et al: Retinoic acid receptor γ mediates topical retinoid efficacy and irritation in animal models. J Invest Dermatol 104:779-783, 1995
88. GOYETTE P, FENG CHEN C, et al: Characterization of retinoic acid receptor-deficient keratinocytes. J Biol Chem 275:16497-16505, 2000
89. HICSONMEZ G: Retinoic acid and steroid in acute promyelocytic leukemia. Leukemia 17:1203, 2003
90. O'DONNELL J: Overview of existing research and information linking isotretinoin (accutane), depression, psychosis, and suicide. Am J Ther 10:148-159, 2003
91. CRANDALL J, SAKAI Y, ZHANG J, et al: 13-cis-retinoic acid suppresses hippocampal cell division and hippocampal-dependent learning in mice. Proc Natl Acad Sci USA 101:5111-5116, 2004
92. DE BOTTON S, DOMBRET H, SANZ M, et al: Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 92:2712-2718, 1998
93. SEGUIN-DEVAUX C, DEVAUX Y, LATGER-CANNARD V, et al: Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARα agonist in vivo. Am J Physiol Endocrinol Metab 283:E525-E535, 2002
94. CHANG MMJ, HARPER R, HYDE DM, WU R: A novel mechanism of retinoic acid-enhanced interleukin-8 gene expression in airway epithelium. Am J Respir Cell Mol Biol 22:502-510, 2000
95. SATO W, KADOMATSU K, YUZAWA Y, et al: Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167:3463-3469, 2001
96. HERDEG C, OBERHOFF M, BAUMBACH A, et al: Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery. Cardiovasc Res 57:544-553, 2003
97. CLAUDEL T, LEIBOWITZ MD, FIEVET C, et al: Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid x receptor. Proc Natl Acad Sci USA 98:2610-2615, 2001
98. WUTTGE DM, ROMERT A, ERIKSSON U, et al: Induction of CD36 by all-trans retinoic acid: Retinoic acid receptor signaling in the pathogenesis of atherosclerosis. FASEB J 15:1221-1223, 2001
99. AZAIS-BRAESCO V, PASCAL G: Vitamin A in pregnancy: Requirements and safety limits. Am J Clin Nutr 71:13255-13335, 2000
100. TANUMIHARDJO SA: Assessing vitamin A status: Past, present and future. J Nutr 134:290S-293S, 2004